TCT 2015: Polymer-Free DES From Medtronic And Biosensors Show Early Promise

Preliminary results from the RevElution trial of Medtronic’s Drug-Filled Stent (DFS) suggest this polymerless metal drug eluting stent may overcome the limitations of current metal and bioabsorbable drug-eluting coronary stents, according to the trial’s co-principal investigator Stephen Worthley of the Royal Adelaide Hospital in Australia.